• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II VALVE, REGULAR; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42866
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 01/21/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The returned valve was patent.It met the requirements for valve flux, siphon, reflux, pressure-flow, and pre-implantation testing.The valve did not pass leak testing due to a tear in the delta chamber.There was surface damage to the proximal occluder.It is unknown how or when the damage to the casing occurred.The ifu cautions, ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting or crushing of component.Such damage may lead to loss of shunt integrity¿¿ all valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported the delta chamber was leaking during the procedure.The valve was replaced and there was no injury to the patient.(b)(6) 2019.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported that because the fluid leakage was found during the implantation process, the same model product was not implanted and replaced in time.According to the surgeon's description, during the implantation process, it was not clear whether there was any device contact with the patient.No additional analysis was performed after the product was removed and sent to the manufacturer.The valve was infiltrated in saline before implantation.It was noted there was no significant effect on the patient.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II VALVE, REGULAR
Common Device Name
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key8346184
Report Number2021898-2019-00054
Device Sequence Number13942981
Product Code JXG
UDI-Device Identifier00613994804648
UDI-Public00613994804648
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K042465
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/29/2020
Device Model Number42866
Device Catalogue Number42866
Device Lot NumberE30431
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/07/2019
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/23/2019
Supplement Date Received by Manufacturer02/19/2019
03/07/2019
Initial Report FDA Received Date02/15/2019
Supplement Report FDA Received Date03/06/2019
03/29/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age60 YR
Patient Weight52
-
-